Books
in black and white
Main menu
Share a book About us Home
Books
Biology Business Chemistry Computers Culture Economics Fiction Games Guide History Management Mathematical Medicine Mental Fitnes Physics Psychology Scince Sport Technics
Ads

Principles and practice of Clinical parasitology - Gillespie S.

Gillespie S. Principles and practice of Clinical parasitology - Wiley publishing , 2001. - 675 p.
ISBN 0-471-97729-2
Download (direct link): principlesandpracticeofclin2001.pdf
Previous << 1 .. 76 77 78 79 80 81 < 82 > 83 84 85 86 87 88 .. 212 >> Next

Palmer KJ, Holliday SM, Brogden RN (1993). Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45: 430-75.
Pasvol G, Newton CRJC, Winstanley PA et al. (1991). Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimes. Am J Trop Med Hyg 45: 702-13.
Pasvol G., Weatherall DJ, Wilson RJM (1977). Effects of fetal hemoglobin on susceptibility of red cells to P. falciparum. Nature 270: 171-3.
Patarroyo ME, Romero P, Torres ML et al. (1987). Inductive of protective immunity against experimental infection with malaria using synthetic peptides. Nature 328: 629-32.
Phillips EJ, Keystone JS, Kain KC (1996). Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America [see comments]. Clin Infect Dis 23: 1171-3.
Phillips-Howard PA, Radalowicz A, Mitchell J et al. (1990). Risk of malaria in British residents returning from malarious areas. Br Med J 300: 499-503.
Phillips-Howard PA, Steffen R, Kerr L et al. (1998). Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 5: 121-6.
Phillips-Howard PA, ter Kuile, FO (1995). CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Safety 12: 370-83.
Phillips-Howard PA, Wood D (1996). The safety of antimalarial drugs in pregnancy. Drug Safety 14: 131-45.
Piessens WF, Hoffman SL, Wadee AA et al. (1985). Antibody-mediated killing of suppressor T lymphocytes as a possible cause of macroglobulinaemia in the tropical splenomegaly syndrome. J Clin Invest 75: 1821-7.
Price R, Nosten F, Luxemburger C et al. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet ii: 701-7.
Radloff PD, Philipps J, Nkeyi M et al. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-14.
Ree GH, Sargeaunt PG (1976). Laboratory diagnosis of malaria. Br Med J 1: 152.
Reeder JC, Cowman AF, Davern KM et al. (1999). The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1. Proc Natl AcadSci USA 96: 5198-202.
Rieckmann KH, Davis DR, Hutton DC (1989). Plasmodium vivax resistance to chloroquine? Lancet 2: 1183-4.
Rieckmann KH, Yeo AET, Davis DR et al. (1993). Recent military experience with malaria chemoprophylxis. Med J Aust 158: 446-9.
Rogers MJ, Li J, McCutchan TF (1998). Developmental regulation and drug target. In Sherman IW (ed.), Malaria. Parasite Biology, Pathogenesis, and Protection. ASM Press: Washington, DC; 203-18.
Rogers WO, Hoffman SL (1999). Malaria Vaccines. In: Malaria. Molecular and Clinical Aspects. Eds M Wahlgren, P Perlmann. Harwood Academic Publishers, pp. 439-94.
Rogerson SJ, Brown GV (1997). Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum infected erythrocytes. Parasitol Today 13: 70-5.
Rogerson SJ, Chaiyaroj S, Ng K et al. (1995). Chondroitin sulphate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 182: 15-20.
Ross R (1897). On some peculiar pigmented cells found in two mosquitos fed on malarial blood. Br Med J 2: 1786-8.
Rowe A, Obeiro J, Newbold CI et al. (1995). Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-6.
Ruwende C, Khoo SC, Snow RW et al. (1995). Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-9.
Samuel BU, Barry M (1998). The pregnant traveller. Infect Dis Clin North Am 12: 325-68.
Schapira A, Fogh S, Jepsen S et al. (1984). Detection of antibodies to malaria: comparison of results with ELISA, IFAT, and crossed immunoelectrophoresis. Acta Pathol Microbiol Immunol Scand B 92: 299-304.
Schlagenhauf P, Steffen R, Tschopp A et al. (1995). Behavioural aspects of travellers in their use of malarial presumptive treatment. Bull WHO 73: 215-21.
Schofield L, Vivas L, Hackett F et al. (1993). Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNFa-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. Ann Trop Med Parasitol 87: 617-26.
Schultz LJ, Steketee RW, Macheso A et al. (1994). The efficacy of antimalarial regimens containing sulphadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-22.
MALARIA
97
Shanks GD, Gordon DM, Klotz FW et al. (1998). Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 27: 494-9.
Shiff CJ, Minjas J, Premji Z (1993). The rapid manual Parasight-F test. A new diagnostic tool for Plasmodium falciparum infection. Trans R Soc Trop Med Hyg 87: 43643.
Sholapurkar S, Gupta A, Mahajan R (1988). Clinical course of malaria in pregnancy: A prospective controlled study from India. Trans R Soc Trop Med Hyg 82: 376-9.
Previous << 1 .. 76 77 78 79 80 81 < 82 > 83 84 85 86 87 88 .. 212 >> Next